19937 results for «»
19937 results
PCR Rio Valves 2025 : Call for Submissions is now open
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Author
Functional or anatomical assessment of non-culprit lesions in acute myocardial infarction
06 Mar 2025
This study demonstrates that OCT-defined TCFA is a superior prognostic marker compared to μQFR for assessing NCLs in AMI patients.

Reviewer
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Author
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial
29 Mar 2025
Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.

Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Author
Pi-Cardia reports first commercial cases with ShortCut™
03 Mar 2025
What is PCR London Valves?
Gore Cardioform ASD occluder implantation for late progression of TR after Triclip
12 Mar 2025
Late progression of TR following T-TEER is not uncommon and may be challenging to treat due to anatomical and technical limitations. This is the 1st report of Gore Cardioform ASD Occluder implantation to treat recurrent severe TR after T-TEER.
Usefulness of FFR-CT to exclude haemodynamically significant lesions in high-risk NSTE-ACS
07 Mar 2025
This single-arm, double-blinded, core-laboratory adjudicated, prospective trial, conducted across four European centers between August 2019 and April 2022, investigates whether CCTA and FFR-CT are able to exclude hemodynamically significant coronary stenoses in patients with high-risk NSTE-ACS.

Reviewer

Reviewer
EuroIntervention Journal: 20 years of excellence
25 Feb 2025
Join the PCR community as we commemorate a big year for EuroIntervention!
In this video, your peers share why they read EuroIntervention and how it impacts their daily practice.

Author

Author

Author

Author

Author

Author

Author

Author

Author

Author

Author
Marcus Franz
Rotenburg an der Fulda, Germany

Kickstart EuroPCR 2026 with Learning & Innovation
Clinical impact of TAVI frame under-expansion and optimisation strategies
07 Mar 2025
Watch this replay with C. Cook, M. Grygier, A. Khokhar and W-K. Kim to learn about the clinical importance of TAVI frame under-expansion, and so much more!
Pacemaker leads and tricuspid interventions: knowns and unknowns
24 Apr 2025
Watch this webinar with F. Praz, J-C. Deharo, J. Dreyfus and B. Mondésert and learn about the mechanisms and risk of interaction between pacemaker lead and the tricuspid valve, and much more!
PCR Perspectives in podcast format
26 Feb 2025
Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with insights and perspectives
Sergio Raposeiras-Roubin
Vigo, Spain

Core Team for PCR Rio Valves 2026
PCR Rio Valves 2026: useful information about the Course
From 2026, PCR Rio Valves is joining forces with TVI by Cardiofy, the conference that’s been gathering cardiac surgeons, interventional cardiologists and imaging specialists in Porto Alegre for the past 4 years.
Our new regional platform aims to foster multidisciplinary interaction for improved decision-making and patient outcomes.